Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun;48(2):268-274.
doi: 10.1177/1073110520935338.

Cannabis as a Gateway Drug for Opioid Use Disorder

Arthur Robin Williams  1
Affiliations

Cannabis as a Gateway Drug for Opioid Use Disorder

Arthur Robin Williams. J Law Med Ethics. 2020 Jun.

Abstract

Cannabis use in some individuals can meaningfully introduce de novo risk for the initiation of opioid use and development of opioid use disorder. These risks may be particularly high during adolescence when cannabis use may disrupt critical periods of neurodevelopment. Current research studying the combination of genetic and environmental factors involved in substance use disorders is poorly understood. More research is needed, particularly to identify which adolescents are most at risk and to develop effective interventions addressing contributing factors such as trauma and psychiatric comorbidity.

PubMed Disclaimer

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Williams AR, “Medical and Recreational Marijuana Policy: From Prohibition to the Rise of Regulation,” in Marijuana and Mental Health, ed. Compton M (Washington, DC: American Psychiatric Publishing Inc., 2016): 39–69;
    2. Williams AR, Olfson M, Kim JD, Martins SS, and Kleber HD, “Older, Less Regulated Medical Marijuana Programs Have Much Greater Enrollment Rates,” Health Affairs 35, no. 3 (2016):480–488. - PMC - PubMed
    1. Humphreys K and Saitz R, “Should Physicians Recommend Replacing Opioids with Cannabis?” JAMA 321, no. 7 (2019): 639–640. - PubMed
    1. Williams AR, Santaella-Tenorio J, Mauro C, Levin FR, and Martins SS, “The Effect of Medical Marijuana Laws and Regulations on Adolescent and Adult Recreational Marijuana use and Cannabis use Disorder,” Addiction 112, no. 11 (2017):1985–1991. - PMC - PubMed
    1. Volkow ND, Swanson JM, Evins AE, et al., “Effects of Cannabis use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review,” JAMA Psychiatry 73, no. 3 (2016): 292–297, available at <doi:10.1001/jamapsychiatry.2015.3278> (last visited April 13, 2020). - DOI - PubMed
    1. Szalavitz M, “Once and for All, Marijuana is Not a Gateway Drug,” Vice News, October 13, 2015.